Term infants
Conditions
Interventions
Bifidobacterium administration during the first month of life.
Placebo
Sponsors
Tokyo Health Care University
Meiji Inc.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Term infants
Exclusion criteria
Exclusion criteria: Without consent Severe co-morbidities
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Growth and development and fecal microflora at 3 years of age | — |
Secondary
| Measure | Time frame |
|---|---|
| Parent-child relationship at 3 years of age | — |
Countries
Japan
Contacts
Public ContactSatoshi Kusuda
Neonatal Research Network of Japan Neonatology
Outcome results
None listed